Joel Kaye is the Director, Pharmacology Project Leader, Discovery & Product Development at Teva Pharmaceuticals. After earning his PhD at the Weizmann Institute of Science in Neuroimmunology he went on to do a fellowship at Harvard Medical School in the field of B-cell tolerance in Xenotransplantation. Joel joined the Pharmacology Department at Teva in 2004, and is currently responsible for non-clinical pharmacology activities related to the MS pipeline. In his spare time, Joel loves to cook and bake.
